MENU
VTGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
VistaGen Therapeutics (VTGN) Ownership - Who owns VistaGen Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
67.66M
P/E Ratio
N/A
Total Cash
97.58M
Projected Growth
N/A
Total Debt
1.79M
Revenue
876K
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash/Share
3.50
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
VTGN
Capitalization
67.7M
P/E Ratio
N/A
Risk (Beta)
0.19
Dividend Yield
N/A
Total Cash
97.6M
Total Cash/Share
3.50
Total Debt
1.79M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
876K
ROE
N/A
Book Value
93M
P/B Ratio
0.73
Cash Flow
N/A
Earnings
-0.74
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
13.29
Current Revenue Per Employee
4066.67
Dividends Per Share - Security
N/A
EBITDA
-45M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-54.69
Shares Held By Institutions
63.7M
Shares Outstanding - Current
27.8M
Total Liabilities
9.52M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-52.724
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of embryonic stem cells for drug discovery and development
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com